Eisai Co. Ltd. v. Lupin Ltd.

COMPLAINT - filed against Lupin Ltd., Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1334545.) - filed by Eisai Inc., Eisai Co. Ltd., Novartis Pharma AG. (Attachments: # 1 Exhibits A-C, # 2 Civil Cover Sheet)(rwc) (Entered: 07/25/2013)

2013-07-24

1

Download

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 07/25/2013)

2013-07-24

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/13/13. Date of Expiration of Patent: (See Form).Thirty Month Stay Deadline: 5/14/2016. (rwc) (Entered: 07/25/2013)

2013-07-24

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1; 7,750,028 B2; 8,076,362 B2. (rwc) (Entered: 07/25/2013)

2013-07-24

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Eisai Co. Ltd., Eisai Inc. identifying Corporate Parent Eisai Corporation of North America, Corporate Parent Eisai Co. Ltd. for Eisai Inc.. (rwc) (Entered: 07/25/2013)

2013-07-24

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharma AG identifying Corporate Parent Novartis AG for Novartis Pharma AG. (rwc) (Entered: 07/25/2013)

2013-07-24

1

View

REQUEST FOR WAIVER of Service sent to Lupin Ltd. on July 26, 2013 by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. Waiver of Service due by 9/26/2013. (Noreika, Maryellen) (Entered: 07/29/2013)

2013-07-29

1

View

WAIVER OF SERVICE returned executed by Eisai Inc., Eisai Co. Ltd., Novartis Pharma AG: For Lupin Ltd. waiver sent on 7/26/2013, answer due 9/24/2013. (Noreika, Maryellen) (Entered: 07/29/2013)

2013-07-29

1

View

REQUEST FOR WAIVER of Service sent to Lupin Pharmaceuticals, Inc. on July 26, 2013 by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. Waiver of Service due by 9/26/2013. (Noreika, Maryellen) (Entered: 07/29/2013)

2013-07-29

1

View

WAIVER OF SERVICE returned executed by Eisai Inc., Eisai Co. Ltd., Novartis Pharma AG: For Lupin Pharmaceuticals Inc. waiver sent on 7/26/2013, answer due 9/24/2013. (Noreika, Maryellen) (Entered: 07/29/2013)

2013-07-29

1

View

MOTION for Pro Hac Vice Appearance of Attorney Joseph M. O'Malley, Jr., Bruce M. Wexler, Young J. Park, and Outi Elina Saviharju - filed by Eisai Co. Ltd., Eisai Inc.. (Blumenfeld, Jack) (Entered: 08/26/2013)

2013-08-26

1

View

ANSWER to 1 Complaint, Defenses, COUNTERCLAIM against Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG by Lupin Ltd., Lupin Pharmaceuticals Inc..(Phillips, John) (Entered: 09/24/2013)

2013-09-24

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Lupin Ltd., Lupin Pharmaceuticals Inc. identifying Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals Inc... (Phillips, John) (Entered: 09/24/2013)

2013-09-24

1

View

MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Sheila N. Swaroop, and Andrea L. Cheek - filed by Lupin Ltd., Lupin Pharmaceuticals Inc.. (Attachments: # 1 Zimmerman Certification, # 2 Swaroop Certification, # 3 Cheek Certification)(Haney, Megan) (Entered: 09/24/2013)

2013-09-24

1

View

ANSWER to 12 Answer to Complaint, Counterclaim /Answer to Lupin Ltd.'s Counterclaims by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG.(Noreika, Maryellen) (Entered: 10/18/2013)

2013-10-18

1

View

ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal to the Court no later than January 6, 2014. The parties are to review the Courts form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, Forms). ORDERED by Judge Leonard P. Stark on 12/10/13. Associated Cases: 1:13-cv-01279-LPS, 1:13-cv-01280-LPS, 1:13-cv-01281-LPS, 1:13-cv-01282-LPS, 1:13-cv-01284-LPS (ntl) (Entered: 12/10/2013)

2013-12-10

1

View

PROPOSED ORDER [Proposed Scheduling Order] re (15 in 1:13-cv-01284-LPS) Order, by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG, Roxane Laboratories Inc., Hetero Labs Ltd., Hetero USA Inc., Mylan Pharmaceuticals Inc., Glenmark Generics Inc. USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Lupin Pharmaceuticals Inc.. (Attachments: # 1 Letter)(Noreika, Maryellen) (Entered: 01/07/2014)

2014-01-07

1

View

SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 1/23/2015. Status Report due by 10/3/2014. Claim Construction Opening Brief due by 10/10/2014. Claim Construction Answering Brief due by 11/7/2014. A Markman Hearing is set for 12/8/2014 at 09:30 AM in Courtroom 6B. A Pretrial Conference is set for 8/17/2015 at 10:00 AM in Courtroom 6B. Proposed Pretrial Order due by 8/7/2015. A 6-day Bench Trial is set for 9/8/2015 at 09:30 AM in Courtroom 6B. Signed by Judge Leonard P. Stark on 1/21/14. (Attachment: # 1 Form of Pretrial Order)Associated Cases: 1:13-cv-01279-LPS, 1:13-cv-01280-LPS, 1:13-cv-01281-LPS, 1:13-cv-01282-LPS, 1:13-cv-01284-LPS (ntl) (Entered: 01/23/2014)

2014-01-23

1

View

NOTICE OF SERVICE of Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc. Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Haney, Megan) (Entered: 01/28/2014)

2014-01-28

1

View

NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG.(Noreika, Maryellen) (Entered: 01/30/2014)

2014-01-30

1

View

STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to March 3, 2014 - filed by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Noreika, Maryellen) (Entered: 02/24/2014)

2014-02-24

1

View

STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to March 10, 2014 - filed by Roxane Laboratories Inc., Hetero Labs Ltd., Hetero USA Inc., Mylan Pharmaceuticals Inc., Glenmark Generics Inc. USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Lupin Pharmaceuticals Inc.. (Phillips, John) (Entered: 03/03/2014)

2014-03-03

1

View

ORDER Setting Teleconference: A Telephone Conference is set for 4/14/2014 at 11:15 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 3/6/2014. Associated Cases: 1:13-cv-01279-LPS, 1:13-cv-01280-LPS, 1:13-cv-01281-LPS, 1:13-cv-01282-LPS, 1:13-cv-01284-LPS(dlk) (Entered: 03/06/2014)

2014-03-06

1

View

Joint PROPOSED ORDER Protective Order by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Noreika, Maryellen) (Entered: 03/10/2014)

2014-03-10

1

View

NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Regarding Electronic Systems Information and (2) Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents filed by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG.(Noreika, Maryellen) (Entered: 03/14/2014)

2014-03-14

1

View

NOTICE OF SERVICE of Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Phillips, John) (Entered: 03/14/2014)

2014-03-14

1

View

Joint STIPULATION and Order of Consolidation by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Noreika, Maryellen) (Entered: 04/07/2014)

2014-04-07

1

View

ORDER Setting Teleconference: A Telephone Conference is set for 1/26/2015 at 11:00 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 4/22/2014. Associated Cases: 1:13-cv-01279-LPS, 1:13-cv-01280-LPS, 1:13-cv-01281-LPS, 1:13-cv-01282-LPS, 1:13-cv-01284-LPS(dlk) (Entered: 04/22/2014)

2014-04-22

1

View

[SEALED] Official Transcript of Pretrial Conference held on October 7, 2015 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. (bpg) Modified on 12/15/2015 (ntl). (Entered: 11/19/2015)

2015-11-19

1

View

ORDER re (288 in 1:13-cv-01279-LPS) MOTION to Redact (285) Transcript, Unopposed Motion to Seal and Redact Transcript filed by Roxane Laboratories Inc. Signed by Judge Leonard P. Stark on 12/15/15. Associated Cases: 1:13-cv-01279-LPS, 1:13-cv-01281-LPS, 1:13-cv-01282-LPS, 1:13-cv-01284-LPS (ntl) (Entered: 12/15/2015)

2015-12-15

1

View

CASE CLOSED Associated Cases: 1:13-cv-01279-LPS, 1:13-cv-01281-LPS, 1:13-cv-01282-LPS, 1:13-cv-01284-LPS (ntl)

2016-10-13

1

No Actions

Terminate Case - Civil

2016-10-13

1

No Actions

Overview

Parties

Plaintiff

Eisai Co. Ltd. Follow

Represented By

Eisai Inc. Follow

Represented By

Novartis Pharma AG Follow

Represented By

Counter Claimant

Lupin Ltd. Follow

Represented By

Lupin Pharmaceuticals Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

COMPLAINT - filed against Lupin Ltd., Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1334545.) - filed by Eisai Inc., Eisai Co. Ltd., Novartis Pharma AG. (Attachments: # 1 Exhibits A-C, # 2 Civil Cover Sheet)(rwc) (Entered: 07/25/2013)

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 07/25/2013)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/13/13. Date of Expiration of Patent: (See Form).Thirty Month Stay Deadline: 5/14/2016. (rwc) (Entered: 07/25/2013)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1; 7,750,028 B2; 8,076,362 B2. (rwc) (Entered: 07/25/2013)

Disclosure Statement pursuant to Rule 7.1 filed by Eisai Co. Ltd., Eisai Inc. identifying Corporate Parent Eisai Corporation of North America, Corporate Parent Eisai Co. Ltd. for Eisai Inc.. (rwc) (Entered: 07/25/2013)

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharma AG identifying Corporate Parent Novartis AG for Novartis Pharma AG. (rwc) (Entered: 07/25/2013)

REQUEST FOR WAIVER of Service sent to Lupin Ltd. on July 26, 2013 by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. Waiver of Service due by 9/26/2013. (Noreika, Maryellen) (Entered: 07/29/2013)

WAIVER OF SERVICE returned executed by Eisai Inc., Eisai Co. Ltd., Novartis Pharma AG: For Lupin Ltd. waiver sent on 7/26/2013, answer due 9/24/2013. (Noreika, Maryellen) (Entered: 07/29/2013)

REQUEST FOR WAIVER of Service sent to Lupin Pharmaceuticals, Inc. on July 26, 2013 by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. Waiver of Service due by 9/26/2013. (Noreika, Maryellen) (Entered: 07/29/2013)

WAIVER OF SERVICE returned executed by Eisai Inc., Eisai Co. Ltd., Novartis Pharma AG: For Lupin Pharmaceuticals Inc. waiver sent on 7/26/2013, answer due 9/24/2013. (Noreika, Maryellen) (Entered: 07/29/2013)

MOTION for Pro Hac Vice Appearance of Attorney Joseph M. O'Malley, Jr., Bruce M. Wexler, Young J. Park, and Outi Elina Saviharju - filed by Eisai Co. Ltd., Eisai Inc.. (Blumenfeld, Jack) (Entered: 08/26/2013)

ANSWER to 1 Complaint, Defenses, COUNTERCLAIM against Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG by Lupin Ltd., Lupin Pharmaceuticals Inc..(Phillips, John) (Entered: 09/24/2013)

Disclosure Statement pursuant to Rule 7.1 filed by Lupin Ltd., Lupin Pharmaceuticals Inc. identifying Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals Inc... (Phillips, John) (Entered: 09/24/2013)

MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Sheila N. Swaroop, and Andrea L. Cheek - filed by Lupin Ltd., Lupin Pharmaceuticals Inc.. (Attachments: # 1 Zimmerman Certification, # 2 Swaroop Certification, # 3 Cheek Certification)(Haney, Megan) (Entered: 09/24/2013)

ANSWER to 12 Answer to Complaint, Counterclaim /Answer to Lupin Ltd.'s Counterclaims by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG.(Noreika, Maryellen) (Entered: 10/18/2013)

NOTICE OF SERVICE of Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc. Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Haney, Megan) (Entered: 01/28/2014)

NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG.(Noreika, Maryellen) (Entered: 01/30/2014)

STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to March 3, 2014 - filed by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Noreika, Maryellen) (Entered: 02/24/2014)

Joint PROPOSED ORDER Protective Order by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Noreika, Maryellen) (Entered: 03/10/2014)

NOTICE OF SERVICE of Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Phillips, John) (Entered: 03/14/2014)

Joint STIPULATION and Order of Consolidation by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Noreika, Maryellen) (Entered: 04/07/2014)

[SEALED] Official Transcript of Pretrial Conference held on October 7, 2015 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. (bpg) Modified on 12/15/2015 (ntl). (Entered: 11/19/2015)

CASE CLOSED Associated Cases: 1:13-cv-01279-LPS, 1:13-cv-01281-LPS, 1:13-cv-01282-LPS, 1:13-cv-01284-LPS (ntl)

Terminate Case - Civil

Track Case Updates

Eisai Co. Ltd.

Eisai Inc.

Novartis Pharma AG

Lupin Ltd.

Lupin Pharmaceuticals Inc.